Deutsche Bank’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84K | Sell |
18,630
-6,220
| -25% | -$28.1K | ﹤0.01% | 3299 |
|
|
2025
Q1 | $115K | Sell |
24,850
-4,214
| -14% | -$19.6K | ﹤0.01% | 3125 |
|
|
2024
Q4 | $202K | Buy |
29,064
+6,633
| +30% | +$46K | ﹤0.01% | 3051 |
|
|
2024
Q3 | $119K | Buy |
22,431
+11,571
| +107% | +$61.3K | ﹤0.01% | 3111 |
|
|
2024
Q2 | $40.6K | Sell |
10,860
-2,528
| -19% | -$9.46K | ﹤0.01% | 3317 |
|
|
2024
Q1 | $94.4K | Sell |
13,388
-571
| -4% | -$4.03K | ﹤0.01% | 3153 |
|
|
2023
Q4 | $78.9K | Hold |
13,959
| – | – | ﹤0.01% | 3278 |
|
|
2023
Q3 | $66.9K | Hold |
13,959
| – | – | ﹤0.01% | 3308 |
|
|
2023
Q2 | $95.6K | Sell |
13,959
-12,319
| -47% | -$84.4K | ﹤0.01% | 3287 |
|
|
2023
Q1 | $205K | Buy |
26,278
+305
| +1% | +$2.38K | ﹤0.01% | 2982 |
|
|
2022
Q4 | $198K | Buy |
25,973
+2,481
| +11% | +$18.9K | ﹤0.01% | 2973 |
|
|
2022
Q3 | $192K | Buy |
23,492
+10,026
| +74% | +$81.9K | ﹤0.01% | 2951 |
|
|
2022
Q2 | $130K | Sell |
13,466
-2,584
| -16% | -$24.9K | ﹤0.01% | 3364 |
|
|
2022
Q1 | $225K | Buy |
16,050
+9,040
| +129% | +$127K | ﹤0.01% | 3178 |
|
|
2021
Q4 | $143K | Sell |
7,010
-688
| -9% | -$14K | ﹤0.01% | 3495 |
|
|
2021
Q3 | $171K | Buy |
+7,698
| New | +$171K | ﹤0.01% | 3610 |
|